Paid Clinical Trials and Focus Groups by Location |
|
|
|
Condition: Breast Density ≥ 50%
Intervention: Procedure: tomosynthesis
Sponsors: Alberta Health Services; Hologic, Inc.
Not yet recruiting - verified March 2010
Condition: Cardiovascular Disease
Interventions: Drug: Active Clonidine; Drug: Placebo Clonidine; Drug: Active ASA; Drug: Placebo ASA
Sponsor: Hamilton Health Sciences
Not yet recruiting - verified March 2010
Condition: Venous Thromboembolism
Intervention: Drug: dabigatran etexilate
Sponsor: Boehringer Ingelheim Pharmaceuticals
Recruiting - verified March 2010
Condition: Pulmonary Arterial Hypertension (Idiopathic, Familial or Anorexigen-associated)
Interventions: Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium; Drug: Dichloroacetate Sodium
Sponsors: University of Alberta; Imperial College London
Enrolling by invitation - verified March 2010
Condition: Acute Asthma
Interventions: Behavioral: Opinion Leader; Behavioral: Usual care
Sponsor: University of Alberta
Not yet recruiting - verified February 2010
Conditions: Castrate-Resistant Prostate Cancer; Hormone Refractory Prostate Cancer
Interventions: Drug: custirsen sodium; Drug: Isotonic, 0.9% sodium chloride
Sponsors: OncoGenex Technologies; Teva Pharmaceuticals USA
Not yet recruiting - verified March 2010
Condition: Arthritis, Psoriatic
Interventions: Drug: ustekinumab; Drug: placebo; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab; Drug: placebo; Drug: ustekinumab; Drug: ustekinumab
Sponsor: Centocor, Inc.
Not yet recruiting - verified February 2010
Conditions: Arrhythmia; Heart Failure
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Conditions: Arrhythmia; Bradycardia
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Conditions: Arrhythmia; Heart Failure
Intervention:
Sponsor: Medtronic Cardiac Rhythm Disease Management
Recruiting - verified February 2010
Condition: Prostate Cancer
Interventions: Drug: HDAC inhibitor SB939; Other: laboratory biomarker analysis
Sponsor: NCIC Clinical Trials Group
Recruiting - verified February 2010
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Insulin Glargine; Drug: LY2189265
Sponsor: Eli Lilly and Company
Recruiting - verified March 2010
Conditions: Migraine; Headache; Pediatric
Intervention: Drug: Normal saline
Sponsor: University of Alberta
Not yet recruiting - verified February 2010
Conditions: Multiple Sclerosis; Optic Neuritis; Minocycline
Intervention: Drug: Minocycline
Sponsors: University of Calgary; Neuroscience Canada
Recruiting - verified February 2010
All Locations ... Canada » ... Alberta 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
